Some 26 attorneys general have signed onto an initiative urging Congress to federally regulate the AI industry “immediately.” One of the voices countering the call is coming from inside the Big Tech arena.
AI-based tools are here to stay, but one expert does not see them replacing cardiologists anytime soon. Look at recent trends in radiology, he says, to get a better idea of what cardiology's future may look like.
A dozen plaintiffs filed a complaint this week, accusing the pharmacy benefit manager of failing to reimburse them for prescriptions at a rate that covers restocking costs.
A new report from the University of Minnesota found that OB/GYN specialty care is drying up nationwide, but healthcare facilities in rural America are the most affected.
Johnson & Johnson is selling key assets related to its Laminar program to a new startup, Jaguar LAA. This comes less than three years after Johnson & Johnson acquired Laminar for $400 million.
Any negotiations are currently in the early stages, sources told Reuters. If a deal closes, Waystar could be taken off the stock market and restructure itself as a private business.
